Two US senators have sent a letter to US Food and Drug Administration officials that raises new concerns about the agency’s legislative plan for a conditional progressive approval pathway for medical devices.
Democrats Elizabeth Warren of Massachusetts and Patty Murray of Washington State – both members of the Senate Health, Education, Labor...